Continued Emergence and Evolution of Omicron in South Africa: New BA.4 and BA.5 lineages

Author:

Tegally Houriiyah,Moir Monika,Everatt Josie,Giovanetti Marta,Scheepers Cathrine,Wilkinson Eduan,Subramoney Kathleen,Moyo Sikhulile,Amoako Daniel G.,Baxter Cheryl,Althaus Christian L.,Anyaneji Ugochukwu J.,Kekana Dikeledi,Viana Raquel,Giandhari Jennifer,Lessells Richard J.,Maponga Tongai,Maruapula Dorcas,Choga Wonderful,Matshaba Mogomotsi,Mayaphi Simnikiwe,Mbhele Nokuzola,Mbulawa Mpaphi B.,Msomi Nokukhanya,Naidoo Yeshnee,Pillay Sureshnee,Sanko Tomasz Janusz,San James E.,Scott Lesley,Singh Lavanya,Magini Nonkululeko A.,Smith-Lawrence Pamela,Stevens Wendy,Dor Graeme,Tshiabuila Derek,Wolter Nicole,Preiser Wolfgang,Treurnicht Florette K.,Venter Marietjie,Davids Michaela,Chiloane Georginah,Mendes Adriano,McIntyre Caitlyn,O’Toole Aine,Ruis Christopher,Peacock Thomas P.,Roemer Cornelius,Williamson Carolyn,Pybus Oliver G.,Bhiman Jinal,Glass Allison,Martin Darren P.,Rambaut Andrew,Gaseitsiwe Simani,Gottberg Anne von,de Oliveira TulioORCID,

Abstract

AbstractSouth Africa’s fourth COVID-19 wave was driven predominantly by three lineages (BA.1, BA.2 and BA.3) of the SARS-CoV-2 Omicron variant of concern. We have now identified two new lineages, BA.4 and BA.5. The spike proteins of BA.4 and BA.5 are identical, and comparable to BA.2 except for the addition of 69-70del, L452R, F486V and the wild type amino acid at Q493. The 69-70 deletion in spike allows these lineages to be identified by the proxy marker of S-gene target failure with the TaqPath™ COVID-19 qPCR assay. BA.4 and BA.5 have rapidly replaced BA.2, reaching more than 50% of sequenced cases in South Africa from the first week of April 2022 onwards. Using a multinomial logistic regression model, we estimate growth advantages for BA.4 and BA.5 of 0.08 (95% CI: 0.07 - 0.09) and 0.12 (95% CI: 0.09 - 0.15) per day respectively over BA.2 in South Africa.

Publisher

Cold Spring Harbor Laboratory

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3